Filters: Author is Di Monte, D A [Clear All Filters]
Sandy MS, Langston JW, Smith MT, Di Monte DA. PCR analysis of platelet mtDNA: lack of specific changes in Parkinson's disease. Mov Disord. 1993;8(1):74-82.
Langston JW, Sastry S, Chan P, Forno LS, Bolin LM, Di Monte DA. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease. Exp Neurol. 1998;154(2):684-90.
Irwin I, Delanney L, Chan P, Sandy MS, Di Monte DA, Langston JW. Nigrostriatal monoamine oxidase A and B in aging squirrel monkeys and C57BL/6 mice. Neurobiol Aging. 1997;18(2):235-41.
Di Monte DA, Harati Y, Jankovic J, Sandy MS, Jewell SA, Langston JW. Muscle mitochondrial ATP production in progressive supranuclear palsy. J Neurochem. 1994;62(4):1631-4.
Di Monte DA, Delanney LE, Irwin I, Royland JE, Chan P, Jakowec MW, et al. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys. Brain Res. 1996;738(1):53-9.
Chan P, Langston JW, Di Monte DA. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum. J Pharmacol Exp Ther. 1993;267(3):1515-20.
Togasaki DM, Tan L, Protell P, Di Monte DA, Quik M, Langston JW. Levodopa induces dyskinesias in normal squirrel monkeys. Ann Neurol. 2001;50(2):254-7.
Di Monte DA, Schipper HM, Hetts S, Langston JW. Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures. Glia. 1995;15(2):203-6.
Langston JW, Quik M, Petzinger G, Jakowec M, Di Monte DA. Investigating levodopa-induced dyskinesias in the parkinsonian primate. Ann Neurol. 2000;47(4 Suppl 1):S79-89.
Di Monte DA, Royland JE, Anderson A, Castagnoli K, Castagnoli N, Langston JW. Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity. J Neurochem. 1997;69(4):1771-3.
Quik M, Police S, Langston JW, Di Monte DA. Increases in striatal preproenkephalin gene expression are associated with nigrostriatal damage but not L-DOPA-induced dyskinesias in the squirrel monkey. Neuroscience. 2002;113(1):213-20.
Thiffault C, Langston JW, Di Monte DA. Increased striatal dopamine turnover following acute administration of rotenone to mice. Brain Res. 2000;885(2):283-8.
Di Monte DA, Tokar I, Langston JW. Impaired glutamate clearance as a consequence of energy failure caused by MPP(+) in astrocytic cultures. Toxicol Appl Pharmacol. 1999;158(3):296-302.
Quik M, Police S, He L, Di Monte DA, Langston JW. Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment. Neuroscience. 2000;98(2):263-73.
Chen L, Togasaki DM, Langston JW, Di Monte DA, Quik M. Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys. Neuroscience. 2005;132(2):409-20.
Chan P, Di Monte DA, Langston JW. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutamate and aspartate in the mouse brain. Brain Res. 1994;647(2):249-54.
Sandy MS, Armstrong M, Tanner CM, Daly AK, Di Monte DA, Langston JW, et al. CYP2D6 allelic frequencies in young-onset Parkinson's disease. Neurology. 1996;47(1):225-30.
Kahle PJ, Jakowec M, Teipel SJ, Hampel H, Petzinger GM, Di Monte DA, et al. Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF. Neurology. 2000;54(7):1498-504.
He L, Di Monte DA, Langston JW, Quik M. Autoradiographic analysis of N-methyl-D-aspartate receptor binding in monkey brain: effects of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and levodopa treatment. Neuroscience. 2000;99(4):697-704.
He L, Di Monte DA, Langston JW, Quik M. Autoradiographic analysis of dopamine receptor-stimulated [(35)S]GTPgammaS binding in rat striatum. Brain Res. 2000;885(1):133-6.
Di Monte DA, Royland JE, Irwin I, Langston JW. Astrocytes as the site for bioactivation of neurotoxins. Neurotoxicology. 1996;17(3-4):697-703.
Irwin I, Delanney LE, McNeill T, Chan P, Forno LS, Murphy GM, et al. Aging and the nigrostriatal dopamine system: a non-human primate study. Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration. 1994;3(4):251-65.

]